BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 319937)

  • 1. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR; Kane RE
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 4. Metolazone, a diuretic agent.
    Stern A
    Am Heart J; 1976 Feb; 91(2):262-3. PubMed ID: 1246936
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic.
    McInnes GT; Clarke JM; Shelton JR
    Clin Pharmacol Ther; 1983 Jan; 33(1):35-43. PubMed ID: 6848297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of combinations of diuretics in nephrotic edema.
    Garin EH
    Am J Dis Child; 1987 Jul; 141(7):769-71. PubMed ID: 3296741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension.
    Van Hoose MC; Cutler RE
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):266-76. PubMed ID: 822985
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined effect of bumetanide and metolazone in normal volunteers.
    Greenberg A; Wallia R; Puschett JB
    J Clin Pharmacol; 1985; 25(5):369-73. PubMed ID: 4031114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Furosemide and metolazone: a highly effective diuretic combination].
    Furrer J; Hess OM; Kuhlmann U; Satz N; Siegenthaler W
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1825-9. PubMed ID: 7280609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.
    McInnes GT; Shelton JR; Perkins RM; Harrison IR; Clarke JM
    Br J Clin Pharmacol; 1983 May; 15(5):564-6. PubMed ID: 6860532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 13. Spironolactone in diuretic regimens with meralluride or thiazides for pseudointractable ascites of cirrhosis.
    Gold H; Golfinos AJ; Mehta D; Messeloff CR; Zahm W
    J Clin Pharmacol New Drugs; 1972 Jan; 12(1):35-9. PubMed ID: 4480885
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metolazone, a new diuretic in essential arterial hypertension].
    Basso B; Gac JC; Rebolledo H; Román O; Valenzuela MA; Cespedes E
    Rev Med Chil; 1986 Feb; 114(2):109-13. PubMed ID: 3532255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of diuretic measures in hydropic condition. 3. Results in nephrotic syndrome, comparison with other disease groups].
    Praetorius F; Neuhaus GA; Horbach L; Michaelis J; Dürr F; Kaufmann W
    Klin Wochenschr; 1969 Nov; 47(21):1152-7. PubMed ID: 5382004
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metolazone in treatment of severe refractory congestive cardiac failure.
    Kiyingi A; Field MJ; Pawsey CC; Yiannikas J; Lawrence JR; Arter WJ
    Lancet; 1990 Jan; 335(8680):29-31. PubMed ID: 1967337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
    Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.
    Haris A; Radó JP
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):332-40. PubMed ID: 10442507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F; Loew D; Dýcka J
    Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.